The natural history of chronic airflow obstruction

C Fletcher, R Peto, C Fletcher, R Peto

Abstract

A prospective epidemiological study of the early stages of the development of chronic obstructive pulmonary disease was performed on London working men. The findings showed that forced expiratory volume in one second (FEV1) falls gradually over a lifetime, but in most non-smokers and many smokers clinically significant airflow obstruction never develops. In susceptible people, however, smoking causes irreversible obstructive changes. If a susceptible smoker stops smoking he will not recover his lung function, but the average further rates of loss of FEV1 will revert to normal. Therefore, severe or fatal obstructive lung disease could be prevented by screening smokers' lung function in early middle age if those with reduced function could be induced to stop smoking. Infective processes and chronic mucus hypersecretion do not cause chronic airflow obstruction to progress more rapidly. There are thus two largely unrelated disease processes, chronic airflow obstruction and the hypersecretory disorder (including infective processes).

References

    1. Br Med J. 1967 Aug 12;3(5562):392-5
    1. Br Med J. 1960 Feb 13;1(5171):450-6
    1. Am Rev Respir Dis. 1964 Jul;90:1-13
    1. Australas Ann Med. 1957 May;6(2):124-40
    1. Lancet. 1953 Sep 26;265(6787):639-43
    1. Thorax. 1967 Jul;22(4):327-35
    1. N Engl J Med. 1969 Feb 20;280(8):397-404
    1. Am Rev Respir Dis. 1968 Oct;98(4):601-10
    1. J Chronic Dis. 1970 Nov;23(5):411-21
    1. Arch Environ Health. 1970 Jul;21(1):50-7
    1. Am J Med. 1966 Jul;41(1):115-29
    1. Am Rev Respir Dis. 1974 Feb;109(2):239-48
    1. Br Med J. 1976 Dec 25;2(6051):1525-36

Source: PubMed

Подписаться